As of 11:11am ET
| +0.0151 / +3.87%|
The 2 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 2.50. The median estimate represents a +640.56% increase from the last price of 0.41.
The current consensus among 2 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.